58 results
6-K
BLRX
Bioline Rx Ltd
18 Jun 24
Current report (foreign)
4:05pm
agreement with Biokine for motixafortide. The lawsuit seeks compensatory damages in the amount of approximately $6.5 million and a declaratory judgment
6-K
EX-10.1
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
Adverse Effect. There is no pending, completed or, to the Company's knowledge, threatened, action (including any lawsuit, arbitration, or legal
424B5
BLRX
Bioline Rx Ltd
1 Apr 24
Prospectus supplement for primary offering
10:30am
the action was brought in the foreign court, a lawsuit in the same matter and between the same parties was pending before a court or tribunal in Israel … in a lawsuit or other proceeding related to the ADSs or the deposit agreement on your behalf or on behalf of any other person;
are not liable
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
a lawsuit and motion to approve the lawsuit as a class action lawsuit pursuant to the Class Action Lawsuits Law 5766-2006 which was filed against us … and the class period relates to the company's statements between February 23, 2021, and September 19, 2022. The total amount claimed, if the lawsuit
F-3
1qw7ok21phwxgjmsj
29 Dec 23
Shelf registration (foreign)
4:15pm
6-K
EX-10.1
xwuaa4e him7j2ct7nif
21 Sep 22
Current report (foreign)
8:00am
424B5
ykceom9q2tskwnx3a
20 Sep 22
Prospectus supplement for primary offering
4:30pm
6-K
EX-10.1
l5b5p2o9q 8th
3 Sep 21
Current report (foreign)
4:30pm
424B5
4ag4ff8 yr5nz8o0
3 Sep 21
Prospectus supplement for primary offering
4:29pm
POS AM
5pviuk6dw 31b4igdm
23 Feb 21
Prospectus update (post-effective amendment)
9:12am
6-K
EX-99
kyafkphc
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
2qz1evl24pdq
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
2jg5r9
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
lryywrepc6w
31 Dec 20
Shelf registration (foreign)
4:37pm
6-K
EX-10.1
r9ma x8me1lb95e8kpjf
25 Sep 20
Current report (foreign)
4:33pm
424B5
1vne rdmxl8
25 Sep 20
Prospectus supplement for primary offering
4:30pm
POS AM
z74g554qk
10 Aug 20
Prospectus update (post-effective amendment)
12:00am
424B3
clt i8azfx
2 Jul 20
Prospectus supplement
4:28pm
F-1
0ulp15b1 3v
26 Jun 20
Registration statement (foreign)
4:30pm